Archive: home delivery

Premium
Time is running out to invest in NowRx. When we urged you to invest last November, it was a compelling opportunity. Since then, it’s gone from compelling to irresistible. Growth has taken off. And Friday is your last chance to invest in this very impressive healthcare startup. Here’s what I said when I recommended NowRx to you last November… With…
Premium

Invest In A Wine Startup With A Massive Inventory

By Andy Gordon on May 28, 2020

Deal Details Startup: Yahyn Security type: Common equity Round size: Up to $20 million Valuation: $4,955,781 Share price: $44.38 Minimum investment: $133.14 Raise: Seed Investment Portal: Netcapital Deadline: June 30, 2020 COVID-19 is changing our world in so many ways. Socially. Professionally.
Premium
Much has changed since we recommended Winc last December. The popular direct-to-consumer wine company was one of the last pre-pandemic recommendations we made. Now lockdowns and quarantines have become our normal. And with so many of us stuck at home, meals have taken center stage in our lives. So it’s…
Premium

NowRx Facing “Unprecedented” Demand

By Andy Gordon on May 18, 2020

When we first recommended NowRx to you in July 2018, its valuation was $20 million. Last November, we recommended you invest in the company again at a $65 million valuation — a more than 3X increase on your original investment price. We were impressed by its execution and…